MS4614: Practical Laboratory in Drug Delivery Systems

Academic Units1
Semester2
Pre-requisite(s)HW0288
Co-requisite(s)MS4612

Course Instructors

Course AIMS

This undergraduate elective module in Nanomedicine aims to:

  • Provide students with a foundational understanding of nanotechnology-based drug delivery systems and their biomedical applications.
  • Develop practical skills in the formulation and encapsulation of therapeutic agents, such as liposomal delivery of anticancer drugs.
  • Introduce key techniques for nanoparticle characterization, including size determination, surface charge, lipid content, and encapsulation efficiency.
  • Equip students with the ability to design and perform in vitro and in vivo assays for evaluating nanoparticle performance, including cellular uptake, cytotoxicity, biodistribution, imaging, and pharmacokinetics.
  • Bridge theoretical concepts with experimental practice through small-group, hands-on laboratory sessions.
  • Cultivate critical thinking, problem-solving, and teamwork skills applicable to translational nanomedicine research.

Intended Learning Outcomes

Upon the successful completion of this course, you (student) would be able to:

  1. Explain the principles of nanomedicine and the rationale for using nanoparticles in drug delivery. 
  2. Formulate a nanoscale drug delivery system (e.g., liposomes) and encapsulate a model therapeutic agent such as doxorubicin.
  3. Apply nanoparticle characterization techniques (e.g., NTA, DLS, zeta potential measurement, lipid quantitation, encapsulation efficiency) and interpret the resulting data.
  4. Design and conduct in vitro assays to evaluate nanoparticle performance, including cellular uptake and cytotoxicity.
  5. Analyze data from in vivo–related applications such as biodistribution, tumour imaging, and pharmacokinetics.
  6. Integrate theoretical knowledge with laboratory findings to assess the potential of nanomedicine approaches in translational research.
  7. Collaborate effectively in small groups to plan, execute, and troubleshoot experimental procedures.
  8. Communicate experimental results and interpretations clearly in an oral presentation using scientific.

Course Content

Session 1 – Formulation of Nanoparticles for Drug Delivery

Lecture/Demo (2h):

o Introduction to nanomedicine and clinical relevance.
o Overview of nanocarriers (liposomes, polymeric nanoparticles, lipid nanoparticles).
o Principles of drug encapsulation (passive vs active loading).
o Introduction to cell culture

Lab (4h):

o Preparation of liposomes via thin-film hydration.
o Encapsulation of doxorubicin (model anticancer drug).
o Observation of vesicle formation.
o Determination of encapsulation efficiency of doxorubicin.

Session 2 – Nanoparticle Characterization and Invitro test

Lecture/Demo (2h):

o Characterization methods: size (DLS, NTA), surface charge (zeta potential)
o Interpreting particle stability and formulation quality.
o In vitro assays: cellular uptake, cytotoxicity

Lab (4h):

o Measurement of liposome size distribution and zeta potential.
o Data collection and analysis.
o Cell uptake (fluorescence microscopy demo with pre-prepared samples).
o Cytotoxicity assay results analysis (provided dataset).

Session 3 – Biological Evaluation and Applications

Lecture/Demo (2h):

o In vivo applications: biodistribution, tumour targeting, imaging, pharmacokinetics.
o Translational considerations (case studies: Doxil, mRNA lipid nanoparticles).

Lab/Data Analysis (4h):

o Invivo biodistribution/imaging observation.
o Data collection and analysis.

Session 4 – Seminar/ Presentation (3h)

Reading and References

The listing below comprises the foundational readings for the course and more up-to-date relevant readings will be provided when they become available.

  • Treatise on Controlled Drug Delivery, A.Kydonieus, Editor. Marcel Dekker, 1992.
  • Biomaterials Science, An Introduction to Materials in Medicine, B.D. Ratner, A.S. Hoffman, F.J. Schoen, J.E. Lemons, 3rd Edition, Academic Press, 2013
  • Handbook of Pharmaceutical Controlled Release Technology, D.L. Wise, 1st Edition, CRC Press, 2000.